The Cadamosto Seamount is an unusual volcanic centre from Cape Verde, characterised by dominantly evolved volcanics, in contrast to the typically mafic volcanic centres at Cape Verde that exhibit only minor volumes of evolved volcanics. The magmatic evolution of Cadamosto Seamount is investigated to quantify the role of magma-crust interaction and thus provide a perspective on evolved end-member volcanism of Cape Verde. The preservation of mantle source signatures by Nd-Pb isotopes despite extensive magmatic differentiation provides new insights into the spatial distribution of mantle heterogeneity in the Cape Verde archipelago. Magmatic differentiation from nephelinite to phonolite involves fractional crystallisation of clinopyroxene, titanite, apatite, biotite and feldspathoids, with extensive feldspathoid accumulation being recorded in some evolved samples. Clinopyroxene crystallisation pressures of 0.38-0.17 GPa for the nephelinites constrain this extensive fractional crystallisation to the oceanic lithosphere, where no crustal assimilants or rafts of subcontinental lithospheric mantle are available. In turn, magma-crust interaction has influenced the Sr, O and S isotopes of the groundmass and late crystallising feldspathoids, which formed at shallow crustal depths reflecting the availability of oceanic sediments and anhydrite precipitated in the ocean crust. The Nd-Pb isotopes have not been affected by these processes of magmacrust interaction and hence preserve the mantle source signature. The Cadamosto Seamount samples have high 206 Pb/ 204 Pb ([19.5), high eNd (?6 to ?7) and negative D8/ 4Pb, showing affinity with the northern Cape Verde islands as opposed to the adjacent southern islands. Hence, the Cadamosto Seamount in the west is located spatially beyond the EM1-like component found further east. This heterogeneity is not encountered in the oceanic lithosphere beneath the Cadamosto Seamount despite greater extents of fractional crystallisation at oceanic lithospheric depths than the islands of Fogo and Santiago. Our data provide new evidence for the complex geometry of the chemically zoned Cape Verde mantle source.
The Xenium In Situ platform is a new spatial transcriptomics product commercialized by 10X Genomics capable of mapping hundreds of transcripts in situ at a subcellular resolution. Given the multitude of commercially available spatial transcriptomics technologies, recommendations in choice of platform and analysis guidelines are increasingly important. Herein, we explore eight preview Xenium datasets of the mouse brain and two of human breast cancer by comparing scalability, resolution, data quality, capacities and limitations with eight other spatially resolved transcriptomics technologies. In addition, we benchmarked the performance of multiple open source computational tools when applied to Xenium datasets in tasks including cell segmentation, segmentation-free analysis, selection of spatially variable genes and domain identification, among others. This study serves as the first independent analysis of the performance of Xenium, and provides best-practices and recommendations for analysis of such datasets.
TissUUmaps is a browser-based tool for GPU-accelerated visualization and interactive exploration of 10⁷+ datapoints overlaying tissue samples. Users can visualize markers and regions, explore spatial statistics and quantitative analyses of tissue morphology, and assess the quality of decoding in situ transcriptomics data. TissUUmaps provides instant multi-resolution image viewing, can be customized, shared, and also integrated in Jupyter Notebooks. We envision TissUUmaps to contribute to broader dissemination and flexible sharing of large-scale spatial omics data.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.